BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11100107)

  • 1. Targeting tumors through the HIF system.
    Ratcliffe PJ; Pugh CW; Maxwell PH
    Nat Med; 2000 Dec; 6(12):1315-6. PubMed ID: 11100107
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription. Oxygen sensing gets a second wind.
    Bruick RK; McKnight SL
    Science; 2002 Feb; 295(5556):807-8. PubMed ID: 11823627
    [No Abstract]   [Full Text] [Related]  

  • 7. HIF-1 as a target for drug development.
    Giaccia A; Siim BG; Johnson RS
    Nat Rev Drug Discov; 2003 Oct; 2(10):803-11. PubMed ID: 14526383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.
    Moeller BJ; Dreher MR; Rabbani ZN; Schroeder T; Cao Y; Li CY; Dewhirst MW
    Cancer Cell; 2005 Aug; 8(2):99-110. PubMed ID: 16098463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
    Mazure NM; Chauvet C; Bois-Joyeux B; Bernard MA; Nacer-Chérif H; Danan JL
    Cancer Res; 2002 Feb; 62(4):1158-65. PubMed ID: 11861398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression.
    Camenisch G; Stroka DM; Gassmann M; Wenger RH
    Pflugers Arch; 2001 Nov; 443(2):240-9. PubMed ID: 11713650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CBP in regulating HIF-1-mediated activation of transcription.
    Ruas JL; Poellinger L; Pereira T
    J Cell Sci; 2005 Jan; 118(Pt 2):301-11. PubMed ID: 15615775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G
    Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iNOS expression inhibits hypoxia-inducible factor-1 activity.
    Yin JH; Yang DI; Ku G; Hsu CY
    Biochem Biophys Res Commun; 2000 Dec; 279(1):30-4. PubMed ID: 11112413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.
    Déry MA; Michaud MD; Richard DE
    Int J Biochem Cell Biol; 2005 Mar; 37(3):535-40. PubMed ID: 15618010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1 (HIF-1) in cancer.
    Quintero M; Mackenzie N; Brennan PA
    Eur J Surg Oncol; 2004 Jun; 30(5):465-8. PubMed ID: 15135470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.
    Nagasawa H; Mikamo N; Nakajima Y; Matsumoto H; Uto Y; Hori H
    Anticancer Res; 2003; 23(6a):4427-34. PubMed ID: 14666730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism.
    Wellmann S; Bührer C; Moderegger E; Zelmer A; Kirschner R; Koehne P; Fujita J; Seeger K
    J Cell Sci; 2004 Apr; 117(Pt 9):1785-94. PubMed ID: 15075239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
    Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
    Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner.
    Takabuchi S; Hirota K; Nishi K; Oda S; Oda T; Shingu K; Takabayashi A; Adachi T; Semenza GL; Fukuda K
    FEBS Lett; 2004 Nov; 577(3):434-8. PubMed ID: 15556623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.